NovaBay Pharma Agrees With BioStem To Commercialize Amniotic Tissue Allograft As Avenova Allograft

NovaBay Pharmaceuticals, Inc. (NBY) announced Monday an agreement to commercialize BioStem Technologies, Inc.'s (BSEM) Amniotic Tissue Allograft as Avenova Allograft. The company plans to launch Avenova Allograft in the coming weeks.

from RTT - Before the Bell https://ift.tt/iv6eQql
via IFTTT

Read More »

BioLineRx: FDA Approves APHEXDA Plus Filgrastim To Mobilize Hematopoietic Stem Cells; Stock Up

BioLineRx Ltd. (BLRX), a commercial stage biopharmaceutical company focused on certain cancers and rare diseases, announced Monday that the U.S. Food and Drug Administration or FDA has approved APHEXDA (motixafortide) in combination with filgrastim (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood. This is for collection and subsequent autologous transplantation in patients with multiple myeloma.

from RTT - Before the Bell https://ift.tt/FqW8g6Z
via IFTTT

Read More »

Kroger Reaffirms FY23 Outlook - Update

While reporting financial results for the second quarter on Friday, supermarket chain Kroger Co. (KR) reaffirmed its adjusted earnings and identical sales outlook for the full-year 2023. Identical sales growth for the second quarter, without fuel, increased 1.0 percent, with underlying growth of 2.6 percent.

from RTT - Earnings https://ift.tt/V2xpv4r
via IFTTT

Read More »

HanesBrands In Licensing Deal With G-III Apparel For Champion And C9 Champion Outerwear

Basic apparel maker HanesBrands, Inc. (HBI) Thursday said it has entered into a strategic multi-year license agreement for Champion and C9 Champion Outerwear with G-III Apparel Group, Ltd. (GIII).

from RTT - Before the Bell https://ift.tt/LmErn53
via IFTTT

Read More »

Science Applications International Q2 Results Top Estimates; Boosts FY24 Outlook

Technology integrator Science Applications International Corp. (SAIC) announced Thursday that net income for the second quarter soared to $247 million or $4.56 per share from $74 million or $1.30 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/la2xPwe
via IFTTT

Read More »

Swiss Life Group H1 Profit Rises On Comparable Basis

Swiss Life Group (SZLMY.PK, SLHN.VX) reported first half net profit of 630 million Swiss francs. In the prior-year, net profit was 560 million francs, on a comparable basis. Under IFRS 17 and the now discontinued IAS 39 standard, prior-year net profit would have been 710 million francs.

from RTT - Earnings https://ift.tt/3GEqieb
via IFTTT

Read More »

Salzgitter Shares Down After Suspending FY23 Outlook As Aurubis Says Won't Reach Target

Shares of Salzgitter AG (SZGPY.PK) were losing around 6 percent in the morning trading in Germany after the steel manufacturer Friday said that it is suspending earnings guidance for fiscal 2023 for the time being. The move follows the outlook revision by non-ferrous metal supplier Aurubis AG (AIAGY.PK), in which Salzgitter holds 29.99 percent stake.

from RTT - Before the Bell https://ift.tt/RYHVbN1
via IFTTT

Read More »